Vertex Pharmaceuticals Inc. buy Barclays PLC
Start price
11.12.23
/
50%
€327.60
Target price
11.12.24
€385.41
Performance (%)
12.36%
Price
30.04.24
€368.10
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC currently has a performance of 12.36%. This prediction currently runs until 11.12.24. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | -2.671% | -2.671% |
iShares Core DAX® | -1.370% | -3.231% |
iShares Nasdaq 100 | 0.172% | -3.339% |
iShares Nikkei 225® | -0.801% | -7.859% |
iShares S&P 500 | -0.369% | -2.979% |
Comments by Barclays_PLC for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Barclays PLC from $408.00 to $415.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€387.70
06.02.24
06.02.24
€439.24
06.02.25
06.02.25
-5.06%
30.04.24
30.04.24